{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:28:58Z","timestamp":1789957738537,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Chinese National Key Technology R&D Program, Ministry of Science and Technology","award":["2023YFC2507204"],"award-info":[{"award-number":["2023YFC2507204"]}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2021-I2M-1-005"],"award-info":[{"award-number":["2021-I2M-1-005"]}]},{"name":"National High Level hospital Clinical Research Funding","award":["2022-PUMCH-B-013"],"award-info":[{"award-number":["2022-PUMCH-B-013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10067-025-07624-4","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:14:57Z","timestamp":1755497697000},"page":"4043-4052","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The distinct subtypes and prognosis of acute myocardial infarction in antiphospholipid syndrome patients"],"prefix":"10.1007","volume":"44","author":[{"given":"Can","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9308-2858","authenticated-orcid":false,"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"21","key":"7624_CR1","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMra1705454","volume":"378","author":"D Garcia","year":"2018","unstructured":"Garcia D, Erkan D (2018) Diagnosis and management of the antiphospholipid syndrome. N Engl J Med 378(21):2010\u20132021. https:\/\/doi.org\/10.1056\/NEJMra1705454","journal-title":"N Engl J Med"},{"issue":"2","key":"7624_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295\u2013306. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"issue":"4","key":"7624_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46(4):1019\u20131027. https:\/\/doi.org\/10.1002\/art.10187","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7624_CR4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","volume":"74","author":"R Cervera","year":"2015","unstructured":"Cervera R, Serrano R, Pons-Estel GJ et al (2015) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 74(6):1011\u20131018. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204838","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"7624_CR5","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/acr.22066","volume":"65","author":"L Andreoli","year":"2013","unstructured":"Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, Ramire de Jesus G, Erkan D (2013) Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res (Hoboken) 65(11):1869\u20131873. https:\/\/doi.org\/10.1002\/acr.22066","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"7624_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MCA.0000000000000476","volume":"28","author":"S Nazir","year":"2017","unstructured":"Nazir S, Tachamo N, Lohani S, Hingorani R, Poudel DR, Donato A (2017) Acute myocardial infarction and antiphospholipid antibody syndrome: a systematic review. Coron Artery Dis 28(4):332\u2013335. https:\/\/doi.org\/10.1097\/MCA.0000000000000476","journal-title":"Coron Artery Dis"},{"issue":"18","key":"7624_CR7","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS et al (2018) Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 72(18):2231\u20132264. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1038","journal-title":"J Am Coll Cardiol"},{"key":"7624_CR8","doi-asserted-by":"publisher","unstructured":"Barbhaiya M, Zuily S, Naden R et al (2023) ACR\/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis  75(10):1687\u20131702. https:\/\/doi.org\/10.1136\/ard-2023-224609","DOI":"10.1136\/ard-2023-224609"},{"key":"7624_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijcha.2018.12.015","volume":"22","author":"H Gandhi","year":"2019","unstructured":"Gandhi H, Ahmed N, Spevack DM (2019) Prevalence of myocardial infarction with non-obstructive coronary arteries (MINOCA) amongst acute coronary syndrome in patients with antiphospholipid syndrome. Int J Cardiol Heart Vasc 22:148\u2013149. https:\/\/doi.org\/10.1016\/j.ijcha.2018.12.015","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"4","key":"7624_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2478\/rir-2022-0033","volume":"3","author":"C Huang","year":"2022","unstructured":"Huang C, Zhao J, Tian X et al (2022) Rheumcloud app: a novel mobile application for the management of rheumatic diseases patients in China. Rheumatology and Immunology Research 3(4):184\u2013189. https:\/\/doi.org\/10.2478\/rir-2022-0033","journal-title":"Rheumatology and Immunology Research"},{"issue":"6","key":"7624_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino Sr","year":"2008","unstructured":"D\u2019Agostino RB Sr, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117(6):743\u2013753. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.699579","journal-title":"Circulation"},{"issue":"25 Suppl 2","key":"7624_CR12","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH et al (2014) 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation 129(25 Suppl 2):S1-45. https:\/\/doi.org\/10.1161\/01.cir.0000437738.63853.7a","journal-title":"Circulation"},{"key":"7624_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijcard.2017.02.155","volume":"240","author":"M Radin","year":"2017","unstructured":"Radin M, Schreiber K, Costanzo P et al (2017) The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction. Int J Cardiol 240:72\u201377. https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.155","journal-title":"Int J Cardiol"},{"key":"7624_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100788","volume":"48","author":"C Cheng","year":"2021","unstructured":"Cheng C, Cheng GY, Denas G, Pengo V (2021) Arterial thrombosis in antiphospholipid syndrome (APS): clinical approach and treatment. A systematic review. Blood Rev 48:100788. https:\/\/doi.org\/10.1016\/j.blre.2020.100788","journal-title":"Blood Rev"},{"issue":"4","key":"7624_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1056\/NEJMoa1312890","volume":"371","author":"G Canaud","year":"2014","unstructured":"Canaud G, Bienaime F, Tabarin F et al (2014) Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med 371(4):303\u2013312. https:\/\/doi.org\/10.1056\/NEJMoa1312890","journal-title":"N Engl J Med"},{"issue":"3","key":"7624_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00281-022-00916-w","volume":"44","author":"JS Knight","year":"2022","unstructured":"Knight JS, Kanthi Y (2022) Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome. Semin Immunopathol 44(3):347\u2013362. https:\/\/doi.org\/10.1007\/s00281-022-00916-w","journal-title":"Semin Immunopathol"},{"issue":"8","key":"7624_CR17","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/rheumatology\/kes388","volume":"52","author":"S Sciascia","year":"2013","unstructured":"Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML (2013) GAPSS: the Global Anti-Phospholipid Syndrome Score. Rheumatology (Oxford) 52(8):1397\u20131403. https:\/\/doi.org\/10.1093\/rheumatology\/kes388","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"7624_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","volume":"7","author":"PL Meroni","year":"2011","unstructured":"Meroni PL, Borghi MO, Raschi E, Tedesco F (2011) Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 7(6):330\u2013339. https:\/\/doi.org\/10.1038\/nrrheum.2011.52","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"7624_CR19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMra1112830","volume":"368","author":"B Giannakopoulos","year":"2013","unstructured":"Giannakopoulos B, Krilis SA (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368(11):1033\u20131044. https:\/\/doi.org\/10.1056\/NEJMra1112830","journal-title":"N Engl J Med"},{"issue":"10","key":"7624_CR20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.114.011201","volume":"131","author":"S Pasupathy","year":"2015","unstructured":"Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF (2015) Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 131(10):861\u2013870. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011201","journal-title":"Circulation"},{"key":"7624_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144595","author":"S Pasupathy","year":"2023","unstructured":"Pasupathy S, La S, Tavella R et al (2023) Do chest pain characteristics in patients with acute myocardial infarction differ between those with and without obstructive coronary artery disease? J Clin Med. https:\/\/doi.org\/10.3390\/jcm12144595","journal-title":"J Clin Med"},{"issue":"1","key":"7624_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s12872-022-02985-z","volume":"22","author":"DA Vorobeva","year":"2022","unstructured":"Vorobeva DA, Ryabov VV, Lugacheva JG, Zavadovsky KV, Mochula AV (2022) Relationships between indicators of prothrombotic activity and coronary microvascular dysfunction in patients with myocardial infarction with obstructive and non-obstructive coronary artery disease. BMC Cardiovasc Disord 22(1):530. https:\/\/doi.org\/10.1186\/s12872-022-02985-z","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"7624_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1742-1241.2006.01245.x","volume":"61","author":"JO Davies","year":"2007","unstructured":"Davies JO, Hunt BJ (2007) Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise. Int J Clin Pract 61(3):379\u2013384. https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01245.x","journal-title":"Int J Clin Pract"},{"issue":"8","key":"7624_CR24","doi-asserted-by":"publisher","first-page":"e17002","DOI":"10.7759\/cureus.17002","volume":"13","author":"V Ramjas","year":"2021","unstructured":"Ramjas V, Jain A, Lee RDM et al (2021) Unraveling the association between myocardial infarction of nonobstructive coronary arteries and antiphospholipid syndrome. Cureus 13(8):e17002. https:\/\/doi.org\/10.7759\/cureus.17002","journal-title":"Cureus"},{"issue":"3","key":"7624_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101503","volume":"48","author":"V Nevras","year":"2023","unstructured":"Nevras V, Milaras N, Katsioulis C et al (2023) Acute coronary syndromes in antiphospholipid syndrome-above suspicion: a systematic review. Curr Probl Cardiol 48(3):101503. https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101503","journal-title":"Curr Probl Cardiol"},{"issue":"10","key":"7624_CR26","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","volume":"78","author":"MG Tektonidou","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M et al (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78(10):1296\u20131304. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7624_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000338347","volume":"122","author":"L Perl","year":"2012","unstructured":"Perl L, Netzer A, Rechavia E et al (2012) Long-term outcome of patients with antiphospholipid syndrome who undergo percutaneous coronary intervention. Cardiology 122(2):76\u201382. https:\/\/doi.org\/10.1159\/000338347","journal-title":"Cardiology"},{"issue":"4","key":"7624_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1536\/ihj.46.631","volume":"46","author":"A Gurlek","year":"2005","unstructured":"Gurlek A, Ozdol C, Pamir G, Dincer I, Tutkak H, Oral D (2005) Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome. Int Heart J 46(4):631\u2013638. https:\/\/doi.org\/10.1536\/ihj.46.631","journal-title":"Int Heart J"},{"issue":"16","key":"7624_CR29","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/0002-9149(92)91216-q","volume":"69","author":"B Eber","year":"1992","unstructured":"Eber B, Schumacher M, Auer-Grumbach P, Toplak H, Klein W (1992) Increased IgM-anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 69(16):1255\u20131258. https:\/\/doi.org\/10.1016\/0002-9149(92)91216-q","journal-title":"Am J Cardiol"},{"issue":"12","key":"7624_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003200","volume":"95","author":"PK Bundhun","year":"2016","unstructured":"Bundhun PK, Boodhoo KD, Long MY, Chen MH (2016) Impact of antiphospholipid syndrome and\/or systemic lupus erythematosus on the long-term adverse cardiovascular outcomes in patients after percutaneous coronary intervention: a systematic review and meta-analysis. Medicine (Baltimore) 95(12):e3200. https:\/\/doi.org\/10.1097\/MD.0000000000003200","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"7624_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcin.2023.10.031","volume":"17","author":"T Koch","year":"2024","unstructured":"Koch T, Lenz T, Rheude T et al (2024) Recurrent revascularization at 10 years after percutaneous treatment of drug-eluting stent restenosis. JACC Cardiovasc Interv 17(1):1\u201313. https:\/\/doi.org\/10.1016\/j.jcin.2023.10.031","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07624-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:23:46Z","timestamp":1760365426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07624-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["7624"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07624-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with the Declaration of Helsinki and was approved by the Medical Ethics Committee of PUMCH (HS-3309).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The written informed consent has been obtained from the subjects (or their legally authorized representative).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This study has been presented at the 25th Asia\u2013Pacific League of Associations for Rheumatology Congress on December 10th, 2023 as an oral presentation. Reference: International Journal of Rheumatic Diseases 2024 Vol. 27 Issue S1 Pages 7\u201365.\u00a0.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior presentation"}}]}}